Literature DB >> 16031449

Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge.

M F Wilkins1, E O'Connell, W A Te Punga.   

Abstract

The aim of this study was to compare the ability of a live incomplete strain (Strain 48) and a live complete strain (Strain 89) of Toxoplasma gondii to protect against abortion and congenital infection following an oral challenge of T. gondii oocysts. Sixty-nine two-tooth ewes were immunised pre-tupping with live Strain 48 of T. gondii tachyzoites and seventy ewes were immunised with Strain 89. Eighty-two serologically negative ewes served as controls. At mid-pregnancy half of the ewes were challenged orally with T. gondii oocysts (2x10(5)/ewe). The ewes vaccinated with Strain 48 were significantly (p<0.05) protected against the effects of experimental challenge and the rate of congenital infection was also significantly (p<0.15) reduced. The ewes vaccinated with Strain 89 were also significantly (p<0.05) protected. The serological response to challenge as measured by both the Dye test and the Indirect Haemagglutination test varied considerably between the two vaccinated groups.

Entities:  

Year:  1988        PMID: 16031449     DOI: 10.1080/00480169.1988.35489

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  9 in total

1.  Use of chicken embryonated eggs for evaluating the virulence of Toxoplasma gondii.

Authors:  A Setasimy; M Namavari
Journal:  J Parasit Dis       Date:  2015-02-14

2.  Investigation of Toxoplasma gondii and association with early pregnancy and abortion rates in New Zealand farmed red deer (Cervus elaphus).

Authors:  Kandarp Khodidas Patel; Elizabeth Burrows; Cord Heuer; Geoffrey William Asher; Peter Raymond Wilson; Laryssa Howe
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

3.  Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

Authors:  A Lundén; K Lövgren; A Uggla; F G Araujo
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

4.  Expression of herpes simplex virus thymidine kinase in Toxoplasma gondii attenuates tachyzoite virulence in mice.

Authors:  J R Radke; M W White
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts.

Authors:  Jun Zou; Xiao-Xi Huang; Guang-Wen Yin; Ye Ding; Xian-Yong Liu; Heng Wang; Qi-Jun Chen; Xun Suo
Journal:  Parasit Vectors       Date:  2011-08-28       Impact factor: 3.876

Review 6.  Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.

Authors:  Maxime W Lemieux; Karine Sonzogni-Desautels; Momar Ndao
Journal:  Pathogens       Date:  2017-12-24

Review 7.  Advances in vaccine development and the immune response against toxoplasmosis in sheep and goats.

Authors:  Tanjila Hasan; Yoshifumi Nishikawa
Journal:  Front Vet Sci       Date:  2022-08-25

8.  Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.

Authors:  Min Meng; Shenyi He; Guanghui Zhao; Yang Bai; Huaiyu Zhou; Hua Cong; Gang Lu; Qunli Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2012-11-26       Impact factor: 3.876

Review 9.  Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs.

Authors:  Milton M McAllister
Journal:  Parasitology       Date:  2014-01-28       Impact factor: 3.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.